
9 Meters Biopharma: A gastrointestinal platform dedicated to addressing rare disorders and unmet needs.
9 Meters Biopharma, founded with a mission to address rare gastrointestinal disorders and unmet medical needs, is a specialized biopharmaceutical company. The company focuses on developing innovative treatments for patients suffering from conditions that lack effective therapeutic options. Their product pipeline includes novel therapies targeting specific gastrointestinal diseases, aiming to improve the quality of life for patients with these challenging conditions.
Notable figures affiliated with 9 Meters Biopharma include experienced professionals in the biopharmaceutical industry, although specific names are not provided. The company has attracted significant investment to support its research and development efforts. Key achievements include advancing multiple drug candidates through various stages of clinical trials, demonstrating their commitment to bringing new treatments to market. Overall, 9 Meters Biopharma has made a substantial impact in the field of gastrointestinal health by focusing on rare and underserved patient populations.
9 Meters Biopharma's most recent funding round was for $5M (USD) in March 2023.
As of Mar 14, 2023, 9 Meters Biopharma has disclosed funding of $129.5M (USD).

Neurogastrx
neurogastrx.com

Petri Bio
petribio.com

Rhythm Pharmaceuticals
rhythmtx.com

Empire Biotechnologies
Microbiome Therapeutics

Bond Biosciences
bond.bio
Metera Pharmaceuticals

Enterin
enterininc.com

BioCryst Pharmaceuticals
biocryst.com

Marius Pharmaceuticals
mariuspharma.com

Palisade Bio
palisadebio.com

Brii Biosciences
briibio.com

Mahzi Therapeutics
mahzi.com

Peak Bio
peak-bio.com

Seres Therapeutics

Intellimedix
intellimedix.com
ZetaRx Biosciences

Gemelli Biotech
gemellibiotech.com

Nine Square Therapeutics
ninesquaretx.com

Woolsey Pharmaceuticals
woolseypharma.com